APA (7th ed.) Citation

A, Z., I, M., D, E., F, I., J, G., S, C., . . . JM, V. (2025). AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signaling. Blood advances, 9(12), 2935. https://doi.org/10.1182/bloodadvances.2024015000

Chicago Style (17th ed.) Citation

A, Zähringer, et al. "AhR Activation Mitigates Graft-versus-host Disease of the Central Nervous System by Reducing Microglial NF-κB Signaling." Blood Advances 9, no. 12 (2025): 2935. https://doi.org/10.1182/bloodadvances.2024015000.

MLA (9th ed.) Citation

A, Zähringer, et al. "AhR Activation Mitigates Graft-versus-host Disease of the Central Nervous System by Reducing Microglial NF-κB Signaling." Blood Advances, vol. 9, no. 12, 2025, p. 2935, https://doi.org/10.1182/bloodadvances.2024015000.